David James Lennon is CEO at Whitehawk Therapeutics, Inc. (WHWK). They have made 6 open-market trades across 2 companies since 2024, most recently 2026-05-14.
CIK 0001995275
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| WHWK | 569,643 | $1.6M |
| AADI | 39,119 | $80K |
| Total | $1.7M |
Shares reported on the most recent Form 4, priced at the 2026-05-18 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| WHWK | SELL | 2026-04-09 | 2026-04-10 | $3.38 | $49K | +22.6% | +10.3% | +11.6% |
| WHWK | SELL | 2026-04-06 | 2026-04-08 | $3.45 | $900K | +26.3% | +18.4% | +24.3% |
| WHWK | SELL | 2026-04-02 | 2026-04-03 | $3.48 | $93K | +11.4% | +19.3% | +19.9% |
| WHWK | SELL | 2026-03-02 | 2026-03-10 | $3.31 | $17K | -10.7% | -11.7% | +0.2% |
| AADI | SELL | 2025-03-03 | 2025-03-03 | $2.35 | $13K | -17.2% | N/A | N/A |
| AADI | SELL | 2024-10-03 | 2024-10-03 | $1.94 | $19K | +7.6% | -1.0% | +58.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.